Molecular remission and response patterns in patients with mutant- [electronic resource]
Producer: 20191018Description: 676-687 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Aged, 80 and over
- Aminopyridines -- therapeutic use
- Biomarkers, Tumor
- Female
- Follow-Up Studies
- Humans
- Isocitrate Dehydrogenase -- antagonists & inhibitors
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Mutant Proteins -- antagonists & inhibitors
- Mutation
- Neoplasm Recurrence, Local -- drug therapy
- Prognosis
- Remission Induction
- Survival Rate
- Triazines -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.